Bayosthiti AI
Bayosthiti AI is an AI-first healthcare company in India pioneering Lifecycle Health, aiming to make proactive, personalized, and participatory care accessible to everyone. They address two key gaps in India's healthcare system: the data gap, by developing diagnostics based on India's unique genetic diversity rather than Western-centric data, and the 'Digital-First' gap, by bridging deep molecular technology with accessible, AI-native digital platforms. Their vision is to build the definitive digital-first health company for India. Their approach focuses on 'Lifecycle Health,' starting with foundational needs like maternal and infant health, infectious diseases, and oncology, and progressing to aspirational wants such as healthspan optimization and longevity. Their core technology is a foundational AI-driven molecular health toolbox, featuring proprietary wet-lab chemistry and advanced AI models. A key innovation is their patented Barcode-Integrated Reverse Transcription (BIRT) technology, which makes advanced RNA sequencing affordable and serves as the engine for building a comprehensive health database for India. Their generative AI models learn from complete transcriptomes, enabling accurate prediction of disease progression and drug response, ushering in an era of precision medicine. Bayosthiti AI offers a suite of affordable molecular tests for Mother & Child Health (NIPT), Infectious Diseases, and Wellness & Longevity, alongside RNAseq services for partners. They also provide AI co-pilot solutions like Bayosthiti Ayu for patients and Bayosthiti Pragyan for clinicians and researchers, aiming to provide end-to-end sample-to-insight and symptom-to-solution capabilities. Their roadmap includes the 'Lifecycle Twin,' a dynamic digital biography of an individual's health from birth to aging, predicting future health and guiding proactive interventions.
Bayosthiti AI
Bayosthiti AI is an AI-first healthcare company in India pioneering Lifecycle Health, aiming to make proactive, personalized, and participatory care accessible to everyone. They address two key gaps in India's healthcare system: the data gap, by developing diagnostics based on India's unique genetic diversity rather than Western-centric data, and the 'Digital-First' gap, by bridging deep molecular technology with accessible, AI-native digital platforms. Their vision is to build the definitive digital-first health company for India. Their approach focuses on 'Lifecycle Health,' starting with foundational needs like maternal and infant health, infectious diseases, and oncology, and progressing to aspirational wants such as healthspan optimization and longevity. Their core technology is a foundational AI-driven molecular health toolbox, featuring proprietary wet-lab chemistry and advanced AI models. A key innovation is their patented Barcode-Integrated Reverse Transcription (BIRT) technology, which makes advanced RNA sequencing affordable and serves as the engine for building a comprehensive health database for India. Their generative AI models learn from complete transcriptomes, enabling accurate prediction of disease progression and drug response, ushering in an era of precision medicine. Bayosthiti AI offers a suite of affordable molecular tests for Mother & Child Health (NIPT), Infectious Diseases, and Wellness & Longevity, alongside RNAseq services for partners. They also provide AI co-pilot solutions like Bayosthiti Ayu for patients and Bayosthiti Pragyan for clinicians and researchers, aiming to provide end-to-end sample-to-insight and symptom-to-solution capabilities. Their roadmap includes the 'Lifecycle Twin,' a dynamic digital biography of an individual's health from birth to aging, predicting future health and guiding proactive interventions.